In focus · trending topic

digestive disease

1 stories · following the connections

Crinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushing’s Disease

By Nasdaq OMXSep 6, 2017, 1:01 PM UTC